Proteomics International is delighted to announce a major milestone in the on-going commercialisation of PromarkerD with the production of a new kit version of our predictive test for diabetic kidney disease.
The PromarkerD kit can be used by pathology laboratories globally, opening the door to new licensing opportunities around the world, and we look forward to providing further updates in the coming months.
